Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodica Stan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Heart Journal|September 14, 2025
Developing therapeutics for rare cardiovascular diseasesJoseph B Lerman, Dwight D Koeberl, Shilpi Epstein, et al.
Molecular Therapy. Methods & Clinical Development|December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cellsDavid L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Human Gene Therapy|June 19, 2026
Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory MeetingsRodica Stan, Richa Madan Lomash, Oleg A Shchelochkov, et al.
The New England Journal of Medicine|February 14, 2024
HIV-1 Remission after Allogeneic Hematopoietic-Cell TransplantationJana K Dickter, Ahmed Aribi, Angelo A Cardoso, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Heart Journal|September 14, 2025
Developing therapeutics for rare cardiovascular diseasesJoseph B Lerman, Dwight D Koeberl, Shilpi Epstein, et al.
Molecular Therapy. Methods & Clinical Development|December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cellsDavid L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Human Gene Therapy|June 19, 2026
Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory MeetingsRodica Stan, Richa Madan Lomash, Oleg A Shchelochkov, et al.
The New England Journal of Medicine|February 14, 2024
HIV-1 Remission after Allogeneic Hematopoietic-Cell TransplantationJana K Dickter, Ahmed Aribi, Angelo A Cardoso, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 2